Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Venous Thromboembolism”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Not applicableEnded earlyNCT00967447
What this trial is testing

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 2
Large-scale testing (Phase 3)Study completedNCT00291330
What this trial is testing

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,564
Large-scale testing (Phase 3)Study completedNCT00680186
What this trial is testing

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,589
Large-scale testing (Phase 3)Study completedNCT01516840
What this trial is testing

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Who this might be right for
Deep Vein Thrombosis
Bayer 60
Post-approval studies (Phase 4)WithdrawnNCT03027167
What this trial is testing

Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty

Who this might be right for
DVT - Deep Vein ThrombosisPE - Pulmonary Thromboembolism
Washington University School of Medicine
Not applicableStudy completedNCT00745212
What this trial is testing

Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women

Who this might be right for
Placental Vascular PathologiesVenous Thromboembolism Diseases
Centre Hospitalier Universitaire de Saint Etienne 2,280
Testing effectiveness (Phase 2)Study completedNCT00395772
What this trial is testing

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Who this might be right for
Venous Thromboembolism
Bayer 543
Testing effectiveness (Phase 2)Study completedNCT03178864
What this trial is testing

Study of Rivaroxaban for CeREbral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
University of British Columbia 55
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Not applicableActive Not RecruitingNCT05491980
What this trial is testing

Florida Cerebrovascular Disease Biorepository and Genomics Center

Who this might be right for
Cerebrovascular DiseaseIschemic StrokeTransient Ischemic Attack+16 more
Mayo Clinic 72
Large-scale testing (Phase 3)Study completedNCT00443053
What this trial is testing

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 3,002
Large-scale testing (Phase 3)Study completedNCT00439725
What this trial is testing

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Who this might be right for
Venous Thromboembolism
Bayer 1,197
Testing effectiveness (Phase 2)UnknownNCT02679664
What this trial is testing

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

Who this might be right for
Venous Thromboembolism
Ottawa Hospital Research Institute 312
Not applicableUnknownNCT01567917
What this trial is testing

Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer

Who this might be right for
Symptomatic Venous ThromboembolismAsymptomatic Venous Thromboembolism
Seoul National University Bundang Hospital 600
Large-scale testing (Phase 3)Study completedNCT00071279
What this trial is testing

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

Who this might be right for
Pulmonary EmbolismDeep Vein Thrombosis
Sanofi 1,215
Not applicableStudy completedNCT01935414
What this trial is testing

Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study

Who this might be right for
Deep Vein Thrombosis
Firstkind Ltd 72
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Large-scale testing (Phase 3)Study completedNCT01516814
What this trial is testing

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

Who this might be right for
Pulmonary Embolism
Bayer 40
Next Page